摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

S,S-bis(8-thiotheophylline) | 180510-53-6

中文名称
——
中文别名
——
英文名称
S,S-bis(8-thiotheophylline)
英文别名
8,8'-disulfanediylbis(1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione);8-[(1,3-dimethyl-2,6-dioxo-7H-purin-8-yl)disulfanyl]-1,3-dimethyl-7H-purine-2,6-dione
S,S-bis(8-thiotheophylline)化学式
CAS
180510-53-6
化学式
C14H14N8O4S2
mdl
——
分子量
422.448
InChiKey
ZIWBLWQPDAZIGG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    28
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    189
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    S,S-bis(8-thiotheophylline)氢氧化钾 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以70%的产率得到dipotassium S,S-bis-8-(thio)-theophyllinate
    参考文献:
    名称:
    8-硫茶碱稳定的新型双核钯磷烷配合物
    摘要:
    已经合成了新的嘌呤衍生物 SS-bis-8-(thio)-theophylline (8-BTTH2) 和 8-phenylthiotheophylline (8-PhTTH),并通过元素分析、质谱和标准光谱测量对其进行了表征。8-BTTH2 与顺式-[PdCl2(PPh3)2] 反应形成双核钯络合物 [Pd(PPh3)(μ-Cl)(8-TT)]2 (8-TTH2 = 8-thiotheophylline)其中发生 PPh3 诱导的 S-S 桥裂解。该配合物与吡啶反应生成不同的二聚钯配合物 [Pd(μ-S,N-8-TT)(PPh3)Py]2,其中两个 8-硫代-(茶碱)阴离子中的每一个都与两种金属结合通过 N7 和 S 原子。还阐明了形成钯配合物的过程。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
    DOI:
    10.1002/ejic.200390047
  • 作为产物:
    描述:
    8-mercapto-1,3-dimethyl-1H-purine-2,6(3H,7H)-dioneN,N-二甲基甲酰胺 为溶剂, 反应 24.0h, 以58%的产率得到S,S-bis(8-thiotheophylline)
    参考文献:
    名称:
    嘌呤苯并噻嗪和吡啶并噻嗪嘌呤衍生物的合成。两个新的杂环系统
    摘要:
    嘌呤[8,7- b ] [1,3]苯并噻嗪和吡啶基[3',2':5,6] [1,3]噻嗪[3,2- f ]这两个新的杂环系统的衍生物的合成嘌呤是由8-巯基茶碱或8-溴茶碱分别与适当取代的苯甲酸或烟酸之间的Ullmann反应影响的。还报道了8,8′-二硫代双茶碱。
    DOI:
    10.1002/jhet.5570350111
点击查看最新优质反应信息

文献信息

  • Synthesis of purinobenzothiazine and pyridothiazinopurine derivatives. Two new heterocyclic ring systems
    作者:Antonio Da Settimo、Anna Maria Marini、Giampaolo Primofiore、Federico Da Settimo、Daniele Bertini
    DOI:10.1002/jhet.5570350111
    日期:1998.1
    The synthesis of derivatives of two new heterocyclic systems, purino[8,7-b][1,3]benzothiazine and pyrido[3′,2′:5,6][1,3]thiazino[3,2-f]purine, was effected by the Ullmann reaction between 8-mercaptotheophylline or 8-bromotheophylline with the appriopriately substituted benzoic or nicotinic acid, respectively. The 8,8′-dithiobistheophylline is also reported.
    嘌呤[8,7- b ] [1,3]苯并噻嗪和吡啶基[3',2':5,6] [1,3]噻嗪[3,2- f ]这两个新的杂环系统的衍生物的合成嘌呤是由8-巯基茶碱或8-溴茶碱分别与适当取代的苯甲酸或烟酸之间的Ullmann反应影响的。还报道了8,8′-二硫代双茶碱。
  • METHODS FOR TREATING OSTEOCLAST-RELATED DISEASE, COMPOUNDS AND COMPOSITIONS THEREOF
    申请人:Holliday Lexie Shannon
    公开号:US20120046246A1
    公开(公告)日:2012-02-23
    This invention relates to therapeutic methods for treating or preventing an osteoclast-related disease or disorder in a subject identified as in need of a treatment of bone diseases, compounds for such uses, and compositions thereof.
  • [EN] METHODS FOR TREATING OSTEOCLAST-RELATED DISEASE, COMPOUNDS AND COMPOSITIONS THEREOF<br/>[FR] PROCÉDÉS DE TRAITEMENT D'UNE MALADIE LIÉE AUX OSTÉOCLASTES, COMPOSÉS ET COMPOSITIONS POUR CEUX-CI
    申请人:UNIV FLORIDA
    公开号:WO2010071826A2
    公开(公告)日:2010-06-24
    This invention relates to therapeutic methods for treating or preventing an osteoclast- related disease or disorder in a subject identified as in need of a treatment of bone diseases, compounds for such uses, and compositions thereof.
  • New Dinuclear Palladium Phosphane Complexes Stabilised by 8‐Thiotheophylline
    作者:Antonio Romerosa、Carlos López‐Magaña、Mustapha Saoud、Sonia Mañas
    DOI:10.1002/ejic.200390047
    日期:2003.1
    binuclear palladium complex [Pd(PPh3)(μ-Cl)(8-TT)]2 (8-TTH2 = 8-thiotheophylline) in which PPh3-induced cleavage of the S−S bridge takes place. This complex reacts with pyridine to give a different dimeric palladium complex, [Pd(μ-S,N-8-TT)(PPh3)Py]2, in which each of the two 8-thio-(theophylline) anions binds two metals through the N7 and S atoms. The process leading to the palladium complex has also
    已经合成了新的嘌呤衍生物 SS-bis-8-(thio)-theophylline (8-BTTH2) 和 8-phenylthiotheophylline (8-PhTTH),并通过元素分析、质谱和标准光谱测量对其进行了表征。8-BTTH2 与顺式-[PdCl2(PPh3)2] 反应形成双核钯络合物 [Pd(PPh3)(μ-Cl)(8-TT)]2 (8-TTH2 = 8-thiotheophylline)其中发生 PPh3 诱导的 S-S 桥裂解。该配合物与吡啶反应生成不同的二聚钯配合物 [Pd(μ-S,N-8-TT)(PPh3)Py]2,其中两个 8-硫代-(茶碱)阴离子中的每一个都与两种金属结合通过 N7 和 S 原子。还阐明了形成钯配合物的过程。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
  • Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM
    作者:Frances M. Bashore、Vittorio L. Katis、Yuhong Du、Arunima Sikdar、Dongxue Wang、William J. Bradshaw、Karolina A. Rygiel、Tina M. Leisner、Rod Chalk、Swati Mishra、C. Andrew Williams、Opher Gileadi、Paul E. Brennan、Jesse C. Wiley、Jake Gockley、Gregory A. Cary、Gregory W. Carter、Jessica E. Young、Kenneth H. Pearce、Haian Fu、Alison D. Axtman
    DOI:10.1371/journal.pone.0293548
    日期:——

    RNA sequencing and genetic data support spleen tyrosine kinase (SYK) and high affinity immunoglobulin epsilon receptor subunit gamma (FCER1G) as putative targets to be modulated for Alzheimer’s disease (AD) therapy. FCER1G is a component of Fc receptor complexes that contain an immunoreceptor tyrosine-based activation motif (ITAM). SYK interacts with the Fc receptor by binding to doubly phosphorylated ITAM (p-ITAM) via its two tandem SH2 domains (SYK-tSH2). Interaction of the FCER1G p-ITAM with SYK-tSH2 enables SYK activation via phosphorylation. Since SYK activation is reported to exacerbate AD pathology, we hypothesized that disruption of this interaction would be beneficial for AD patients. Herein, we developed biochemical and biophysical assays to enable the discovery of small molecules that perturb the interaction between the FCER1G p-ITAM and SYK-tSH2. We identified two distinct chemotypes using a high-throughput screen (HTS) and orthogonally assessed their binding. Both chemotypes covalently modify SYK-tSH2 and inhibit its interaction with FCER1G p-ITAM, however, these compounds lack selectivity and this limits their utility as chemical tools.

    RNA测序和遗传学数据支持将脾脏酪氨酸激酶(SYK)和高亲和性免疫球蛋白epsilon受体亚基γ(FCER1G)作为阿尔茨海默病(AD)治疗的潜在调控靶点。FCER1G 是含有基于免疫受体酪氨酸的激活基序(ITAM)的 Fc 受体复合物的一个组成部分。SYK 通过其两个串联 SH2 结构域(SYK-tSH2)与双重磷酸化 ITAM(p-ITAM)结合,从而与 Fc 受体相互作用。FCER1G p-ITAM 与 SYK-tSH2 相互作用,通过磷酸化激活 SYK。据报道,SYK 的活化会加重 AD 的病理变化,因此我们推测破坏这种相互作用会对 AD 患者有益。在此,我们开发了生化和生物物理检测方法,以发现能扰乱 FCER1G p-ITAM 和 SYK-tSH2 之间相互作用的小分子。我们通过高通量筛选(HTS)确定了两种不同的化学型,并对它们的结合进行了正交评估。这两种化学型都能共价修饰 SYK-tSH2,抑制其与 FCER1G p-ITAM 的相互作用,但是这些化合物缺乏选择性,这限制了它们作为化学工具的效用。
查看更多